TLR4/NF-κB signaling pathway plays an important role in cardiomyocyte inflammation and apoptosis and can be targeted to alleviate myocardial ischemia/reperfusion injury and diabetic cardiomyopathy [42–47]. Here, TLR4 is linked to diabetic cardiomyopathy.